Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$274,291
+$274,291 QoQ
Shares Held
1,440
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,632
of 2,098 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Derivatives in DHR
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$459,100
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $1,163,103 across 2 Diagnostics & Research names. DHR ranks #2 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
4,600 | $888,812 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,440 | $274,291 |
All Filings in DHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $274,291 | 1,440 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $459,100 | 2,000 | Put | Sole | 2025-02-18 | |
| 2022-12-31 | $6,492,438 | 24,461 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,886,269 | 26,661 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,603,143 | 10,268 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,154,356 | 20,981 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,743,907 | 23,537 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,574,344 | 8,456 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $3,670,283 | 20,756 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||